Advances in 3D Cell Culture is an event that aims to promote research and networking in this field of science by providing hands-on training opportunities, conferences, lectures, research poster presentations, and the display of products and solutions on current and emerging topics in the area of 3D cell culture. In our upcoming conference, attendees will have the opportunity to network with experts, gain insight into how startups and industry are utilizing 3D cell culture technologies to accelerate research and development, and discuss the potential of in-vitro cell culture models in replacing animal models. Additionally, attendees will have the opportunity to gain knowledge about developments in artificial organ engineering, with a special focus on organoids and spheroids, organ-on-chip, 3D bioprinting, data analysis, and regulatory guidelines for alternatives to animal testing methods. The larger goal is to fuel collaborations between different researchers working in this area, streamline and harmonize their efforts, and improve the preparedness of our country to adopt such models for biological, preclinical, and toxicological research.

Event Highlights:

Two day International Conference on Advances in 3D Cell Culture: Join thought-provoking discussions, keynote presentations, and panel sessions led by global leaders in the field. Explore the latest advancements, breakthroughs, and applications of 3D cell culture methodologies.

TALK SESSIONS :

Session 1: Advances in organoids and tumoroid developments: characterization and applications

Organoids and spheroids are cutting-edge three-dimensional cell culture models that have revolutionized biomedical research. These miniature structures greatly resemble organs and tissues and are grown in vitro. They allow researchers to closely mimic the behavior of human tissues and organs, providing insights into drug efficacy, toxicity, and disease progression. Their 3D nature more accurately represents the in vivo conditions, making them crucial tools in advancing our understanding of human biology and developing novel therapeutic strategies.

Speakers

Session 2: 3D bioprinting for the development of artificial organs

3D bioprinting, a revolutionary technique, combines the engineering genius of 3D printing and the potential of biological sciences, to print complex, functional tissue and organ systems using building blocks like cells and biopolymers. This technique has significant applications in th field of organ transplantation, regenratibe medicine, drug toxicity screening and much more.

Speakers

Session 3: AI/ML and Data analysis in 3D culture

Learn about the potential of AIML in data processing of 3D cell culture-based models.

Session 4: Organ-on-a-chip for preclinical and biological research

Organ-on-chip systems are micro-engineered systems that, while not visually identical to human organs, mimic the mechanical properties as well as the functioning of a living organ. They are embedded with microchambers and microvessels that allow a continuous supply of nutrients and oxygen. Organ-on-chip models, often abbreviated as OOCs, provide physiological relevant and yet powerful alternatives to existing 2D and animal models for researchers in academia and pharmaceutical industries for a wide range of biomedical applications.

Speakers

Session 5: Regulatory guidelines for alternative to animal testing methods

Over the past few years, 3D cell culture methods have gained increasing interest as alternative to animal models for preclinical and biological research, owing to their benefits over the conventional animal models. Based on their importance and potential, the FDA Modernization
Act 2.0, emphasizes on adoption of the alternative methods to animal testing, such as the computational methods and the microphysiological systems.

Speakers

PLATFORM SESSIONS

CRO showcase

Contact research organizations have the knowledge, capabilities, processes and procedures that are needed to develop and run a successful clinical trial, while ensuring trial quality and compliance with national and international standards. Working with a contract research organization can offer innovative tools that can increase efficiencies, leading to decreased timelines and cost. Do not miss this opportunity of getting introduced to and connecting with a number of CROs working in the field of 3D cell culture.

Dr. Kasturi Mahadik will be the moderator of this session.

Future of alternative to animal models (Start-up pitch)

In this platform session, we provide a platform to the up-and-coming start-ups working in the 3D cell culture to present their unique and innovative ideas and services. Start-ups are the future companies set to rule the market. Join us the conference and make sure you have these future leaders in your network!

POSTER PRESENTATION

Participate in our interactive poster sessions to present your work and engage with professionals at the top of the field. This is your chance to network with leading experts, share your research, and gain valuable insights. Interact with peers and subject matter experts, fostering meaningful connections and discussions. Plus, there are exciting prizes and acknowledgments awaiting the most outstanding contributions.

Don’t miss this opportunity to showcase your research and advance your career!

Focus on:

• 3D Bioprinting
• Organoids, spheroids, and Tumoroids
• Organ-on-Chip
• Tissue Engineering and Toxicology Applications

3D CELL CULTURE EXHIBITION

The 3D cell culture Expo provides a platform for Industry and Startups to revitalize and showcase cell culture related products, instrumentations and technological innovation to attendees of the conference.

Why you should not miss this!

• Build new business relationships in Cell culturel Industry.
• Gain industry knowledge and enhance collaboration.
• Present and discuss your ideas with peers and leaders.
• Have access to leads and raise brand awareness.
• Meet a diverse set of successful and engaging industry professionals.
• Network with like-minded individuals, industry decision-makers, and senior leaders in the Cell Culture sector.